Drug Discovery World

SEPTEMBER 4, 2023

SLAS2024 event partner DDW will be the exclusive sponsor for the SLAS Ignite Theater, hosting its own free to attend seminar series, ‘Innovation & technology: from lab to patient’. How using technology to identify previously undruggable targets has enabled the development of therapeutics and vaccines.

Vaccine 130

Vaccine Science Pharmaceuticals Disease 130

Drug Discovery World

AUGUST 5, 2022

For the first time, a series of short seminars focused on automation will be available to visitors of Drug Discovery 2022 (4-5 Oct, London, UK). DDW partners with ELRIG at Drug Discovery 2022.

International 130

International Pharmaceutical Companies Drugs Vaccine 130

Agency IQ

MARCH 29, 2024

regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0: regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0:

Regulations 40

Regulations Production Biosimilars Clinical Trials 40

Agency IQ

MAY 31, 2024

There will also be a number of noteworthy conferences taking place this month pertaining to the vaccine and medical technology industries. Many of these webinars and trainings sessions are geared towards medical devices and in vitro diagnostics (IVDs). s Medicines and Healthcare products Regulatory Agency (MHRA).

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

Agency IQ

OCTOBER 27, 2023

Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?

Regulations 40

Regulations Pharmaceuticals Production Packaging 40

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Organization 2/28/2024 2/28/2024 Workshop on Medical Radioisotopes Conference ( CLOSED ) Belgian Council Presidency 2/28/2024 2/28/2024 The path to diagnosis – the challenge of rare diseases Webinar/ Seminar ( OPEN ) Martin Zeitz Center for Rare Diseases at the University Hospital Hamburg-Eppendorf 2/28/2024 (..)

Regulations 40

Regulations Biosimilars Clinical Trials Production 40

KIF1A

MAY 4, 2024

Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. By talking to groups with these mutations, we may identify other diseases whose patients have KIF1A variants. She once worked at SACELLS Biotechnology Co.

Science 116

Science Medical Schools RNA Research 116